Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Melphalan × Breast × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 14 Observational 1

Sponsor

Cancer Type

Plasma cell 3 Classical hematology 2 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Breast 1

Conditions

Neoplasms 1 Muscle Neoplasms 1 Chronic Pain 1 Breast Neoplasms 1

Interventions

Surveys and Questionnaires 69 Blood Specimen Collection 52 palbociclib 31 Trastuzumab 30 Drug Therapy 27 Radiotherapy 25 Letrozole 24 Immunohistochemistry 23 Anastrozole 23 Tamoxifen 19 exemestane 18 Interviews as Topic 18 Gene Expression Profiling 18 Fulvestrant 18 Biopsy 18 Amplified Fragment Length Polymorphism Analysis 18 ribociclib 17 Mastectomy, Segmental 17 Magnetic Resonance Spectroscopy 15 Specimen Handling 14 Capecitabine 14 Mastectomy 13 trastuzumab deruxtecan 12 Psychiatric Rehabilitation 12 Observation 12 Neoadjuvant Therapy 12 Mammography 12 High-Energy Shock Waves 12 Polymerase Chain Reaction 11 Cyclophosphamide 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06154590 2023-12-04

NASBP-B-09

Paradyne Networks A Foundation

Not yet recruiting

Breast Neoplasms, Neoplasms, Muscle Neoplasms, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡